Hyperfine (NASDAQ:HYPR – Free Report) had its price target decreased by B. Riley from $1.50 to $1.20 in a research note issued to investors on Thursday morning,Benzinga reports. B. Riley currently has a buy rating on the stock.
Separately, Wells Fargo & Company raised their price objective on shares of Hyperfine from $1.10 to $1.29 and gave the company an “equal weight” rating in a research note on Tuesday, March 18th.
Read Our Latest Research Report on HYPR
Hyperfine Stock Performance
Hyperfine (NASDAQ:HYPR – Get Free Report) last announced its quarterly earnings data on Monday, March 17th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.02. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The firm had revenue of $2.32 million during the quarter, compared to analysts’ expectations of $2.30 million. During the same quarter last year, the business earned ($0.15) earnings per share. Equities analysts forecast that Hyperfine will post -0.57 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Hyperfine
Several hedge funds have recently added to or reduced their stakes in HYPR. Geode Capital Management LLC increased its holdings in Hyperfine by 18.7% during the 3rd quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock valued at $675,000 after acquiring an additional 98,335 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Hyperfine by 32.9% during the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after acquiring an additional 52,500 shares in the last quarter. Graypoint LLC purchased a new position in Hyperfine during the 4th quarter valued at about $44,000. Wealth Enhancement Advisory Services LLC increased its holdings in Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after acquiring an additional 32,093 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in Hyperfine during the 4th quarter valued at about $25,000. 15.03% of the stock is currently owned by hedge funds and other institutional investors.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
See Also
- Five stocks we like better than Hyperfine
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How to Invest in the Best Canadian Stocks
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Short a Stock in 5 Easy Steps
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.